Results 121 to 130 of about 1,027,416 (202)
BACKGROUND: Carbapenem-resistant Enterobacterales (CRE) are increasing in the UK, but the drivers of this rise and effective treatment options remain uncertain.
Jacquelyn McCormick (6861608) +50 more
core +3 more sources
Antimicrobial resistance is a significant public health issue. In addressing the threat of multidrug resistant bacterial infections, carbapenems have been used.
Ahmad A. Alshehri +1 more
core +1 more source
The Practicability of Carbapenem-resistant Enterobacterales Surveillance Culture
openaire +1 more source
Evolution of carbapenem-resistant Enterobacterales strains isolated in Dakar
Introduction : La résistance aux antibiotiques constitue aujourd’hui l’une des menaces les plus graves pour la santé mondiale, la sécurité alimentaire et le développement. On observe une augmentation du nombre de bactéries résistantes aux antibiotiques, notamment dans les hôpitaux, depuis quelques décennies.
Abdou Diop +16 more
openaire +1 more source
Characteristics of Carbapenem Resistance Enterobacterales (CRE) From a Local Poultry Farm
Carbapenem antibiotics are often administered to poultry in order to reduce illness, prevent disease, and boost their growth. In humans, carbapenem is always used as a last resort antibiotic in multidrug resistance bacteria (MDR).
Mohd Zabidi, Umi Nabilah +1 more
core
Efficacy of eravacycline on carbapenem resistant Enterobacterales in vitro
The main obstacle in treatment of infections caused by carbapenem-resistant Enterobacterales (CRE) are limited treatment options. The novel antimicrobial agents other than β-lactams with activity not being dependent on β-lactamase class are especially important.
openaire +1 more source
Antimicrobial Resistance Trends in Carbapenem-Resistant Enterobacterales in a Saudi Healthcare Setting. [PDF]
Alghamdi WA +4 more
europepmc +1 more source
Carbapenem-resistant Enterobacterales in Europe: strengthening AMR resilience through coordinated system-level action - lessons from Ukraine. [PDF]
Martin L +13 more
europepmc +1 more source
BACKGROUND: Both carbapenem and piperacillin-tazobactam (TZP) use have been reported as risk factors for carbepenem-resistant Enterobacterales (CRE) infections.
Gökçen Telli +6 more
core +1 more source
Carbapenem-Resistant Enterobacterales (CRE) in Europe: Surveillance Challenges, Emerging Threats and Public Health Preparedness. [PDF]
Kuszewska K +3 more
europepmc +1 more source

